← Back to Search

Procedure

Abnormal Ovarian Ultrasound for Ovarian Tumors

N/A

Waitlist Available

Research Sponsored by Frederick R. Ueland, M.D.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

Study Summary

This trial will see if using a special kind of ultrasound can help distinguish between benign and malignant ovarian tumors, potentially reducing the number of false positive results.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Positive predictive value (PPV) of ovarian cancer screening

Secondary outcome measures

Compliance to the treatment algorithm

Surgical complications

Trial Design

1Treatment groups

Experimental Treatment

Group I: Abnormal Ovarian UltrasoundExperimental Treatment1 Intervention

Abnormal Ovarian Ultrasound

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Abnormal Ovarian Ultrasound

2016

N/A

~180

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Frederick R. Ueland, M.D.Lead Sponsor

4 Previous Clinical Trials

654 Total Patients Enrolled

Lucille P. Markey Cancer Center at University of KentuckyOTHER

3 Previous Clinical Trials

353 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum number of participants accepted in this investigation?

"Affirmative. The information available on clinicaltrials.gov signals that this medical study is actively recruiting, having been initially posted on September 1st 2016 and revised most recently on October 18th 2022. To complete the trial, 3290 subjects need to be recruited from a single centre."

Answered by AI

Are researchers still enrolling for this clinical exploration?

"Clinicaltrials.gov reports confirm that patient recruitment for this medical trial has begun, having been posted on September 1st 2016 and most recently edited October 18th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors

Frederick R. Ueland, M.D. 2016. "Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02227654.